189 related articles for article (PubMed ID: 36263421)
1. Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma.
Li Y; Huang H; Jiang M; Yu N; Ye X; Huang Z; Chen L
Front Genet; 2022; 13():975279. PubMed ID: 36263421
[No Abstract] [Full Text] [Related]
2. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
Chen J; Fu Y; Hu J; He J
Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
6. A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.
Wang Y; Feng J; Liu Y; Han T
Comput Math Methods Med; 2022; 2022():7165851. PubMed ID: 36213576
[TBL] [Abstract][Full Text] [Related]
7. Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma.
Li F; Song QZ; Zhang YF; Wang XR; Cao LM; Li N; Zhao LX; Zhang SX; Zhuang XF
Front Genet; 2022; 13():1008416. PubMed ID: 36186418
[No Abstract] [Full Text] [Related]
8. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
9. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
10. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
11. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
Front Genet; 2022; 13():975905. PubMed ID: 36313456
[No Abstract] [Full Text] [Related]
12. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
13. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
14. Screening and Identification of Four Prognostic Genes Related to Immune Infiltration and G-Protein Coupled Receptors Pathway in Lung Adenocarcinoma.
Wang Y; Qiu L; Chen Y; Zhang X; Yang P; Xu F
Front Oncol; 2020; 10():622251. PubMed ID: 33628734
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network.
Zhang J; Chen A; Xue Z; Liang C
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):334-346. PubMed ID: 36351297
[No Abstract] [Full Text] [Related]
16. A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma.
Ma S; Zhu J; Wang M; Han T; Zhu J; Jiang R; Jiang T
Ann Transl Med; 2022 Apr; 10(8):479. PubMed ID: 35571443
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
[TBL] [Abstract][Full Text] [Related]
18. Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma.
Dai Z; Liu T; Liu G; Deng Z; Yu P; Wang B; Cen B; Guo L; Zhang J
Front Mol Biosci; 2021; 8():757421. PubMed ID: 34869590
[No Abstract] [Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
Zhou J; Wang X; Li Z; Jiang R
FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
